Article Type
Changed
Wed, 04/17/2019 - 15:32
Display Headline
VIDEO: Public testimony gets heated at FDA panel meeting on morcellation

SILVER SPRING, MD. – Power morcellation devices should be never used for gynecologic procedures, Dr. Hooman Noorchashm testified to a Food and Drug Administration expert panel on July ll.

He called out members of the FDA Obstetrics and Gynecology Devices Panel Advisory Committee by name, seeking to shame them into action to disallow power morcellation for suspected uterine fibroids.

"Is this a safe and logical device?" said Dr. Noorchashm, a cardiothoracic surgeon at Brigham and Women’s Hospital in Boston. "The only classification for this device is banned – unsafe, illogical, incorrect, and deadly."

Dr. Noorchashm’s wife, Dr. Amy Reed, had a hysterectomy with morcellation for suspected fibroids. Biopsy later confirmed sarcoma was present. Use of power morcellation caused tumor cells to spread, upstaging her sarcoma to stage IV.

dfulton@frontlinemedcom.com

On Twitter @denisefulton

Publications
Topics
Legacy Keywords
Power morcellation devices, gynecologic procedures, Dr. Hooman Noorchashm, FDA, Food and Drug Administration, Obstetrics and Gynecology Devices Panel Advisory Committee, power morcellation, uterine fibroids,
Related Articles

SILVER SPRING, MD. – Power morcellation devices should be never used for gynecologic procedures, Dr. Hooman Noorchashm testified to a Food and Drug Administration expert panel on July ll.

He called out members of the FDA Obstetrics and Gynecology Devices Panel Advisory Committee by name, seeking to shame them into action to disallow power morcellation for suspected uterine fibroids.

"Is this a safe and logical device?" said Dr. Noorchashm, a cardiothoracic surgeon at Brigham and Women’s Hospital in Boston. "The only classification for this device is banned – unsafe, illogical, incorrect, and deadly."

Dr. Noorchashm’s wife, Dr. Amy Reed, had a hysterectomy with morcellation for suspected fibroids. Biopsy later confirmed sarcoma was present. Use of power morcellation caused tumor cells to spread, upstaging her sarcoma to stage IV.

dfulton@frontlinemedcom.com

On Twitter @denisefulton

SILVER SPRING, MD. – Power morcellation devices should be never used for gynecologic procedures, Dr. Hooman Noorchashm testified to a Food and Drug Administration expert panel on July ll.

He called out members of the FDA Obstetrics and Gynecology Devices Panel Advisory Committee by name, seeking to shame them into action to disallow power morcellation for suspected uterine fibroids.

"Is this a safe and logical device?" said Dr. Noorchashm, a cardiothoracic surgeon at Brigham and Women’s Hospital in Boston. "The only classification for this device is banned – unsafe, illogical, incorrect, and deadly."

Dr. Noorchashm’s wife, Dr. Amy Reed, had a hysterectomy with morcellation for suspected fibroids. Biopsy later confirmed sarcoma was present. Use of power morcellation caused tumor cells to spread, upstaging her sarcoma to stage IV.

dfulton@frontlinemedcom.com

On Twitter @denisefulton

Publications
Publications
Topics
Article Type
Display Headline
VIDEO: Public testimony gets heated at FDA panel meeting on morcellation
Display Headline
VIDEO: Public testimony gets heated at FDA panel meeting on morcellation
Legacy Keywords
Power morcellation devices, gynecologic procedures, Dr. Hooman Noorchashm, FDA, Food and Drug Administration, Obstetrics and Gynecology Devices Panel Advisory Committee, power morcellation, uterine fibroids,
Legacy Keywords
Power morcellation devices, gynecologic procedures, Dr. Hooman Noorchashm, FDA, Food and Drug Administration, Obstetrics and Gynecology Devices Panel Advisory Committee, power morcellation, uterine fibroids,
Article Source

AT AN FDA ADVISORY COMMITTEE MEETING

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.